SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-24-000035
Filing Date
2024-07-31
Accepted
2024-07-31 06:31:21
Documents
81
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20240630.htm   iXBRL 10-Q 2109082
2 EX-10.2 uthrex10206302024.htm EX-10.2 19063
3 EX-10.3 uthrex10306302024.htm EX-10.3 13689
4 EX-31.1 uthrex31106302024.htm EX-31.1 11940
5 EX-31.2 uthrex31206302024.htm EX-31.2 11946
6 EX-32.1 uthrex32106302024.htm EX-32.1 6645
7 EX-32.2 uthrex32206302024.htm EX-32.2 6772
  Complete submission text file 0001082554-24-000035.txt   9517547

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20240630.xsd EX-101.SCH 53252
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20240630_cal.xml EX-101.CAL 72943
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20240630_def.xml EX-101.DEF 277788
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20240630_lab.xml EX-101.LAB 725998
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20240630_pre.xml EX-101.PRE 498384
84 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20240630_htm.xml XML 1584890
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 241159780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)